Investigation of ResMed, Inc.

Robbins LLP Is Investigating the Officers and Directors of ResMed Inc. (RMD) on Behalf of Shareholders

February 10, 2020 (San Diego, CA & Poway, CA) – Shareholder rights law firm Robbins LLP reminds investors that it is investigating whether certain officers and directors of ResMed Inc. (NYSE: RMD) breached their fiduciary duties to shareholders.  ResMed develops, manufactures, and markets medical equipment for the treatment of sleep disordered breathing.

 

Send us a message for more information.

Protect your investments.

Sign up for free investment monitoring.

Stock Watch members receive free investment monitoring and notifications.  

Leave your details to get started

"*" indicates required fields

Name*
Ticker + Amount
This field is for validation purposes and should be left unchanged.

Skip to content